These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28819235)

  • 21. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
    Jiao M; Guo H; Chen Y; Li L; Zhang L
    Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Su H; Sun T; Wang H; Shi G; Zhang H; Sun F; Ye D
    Oncotarget; 2017 Jan; 8(4):5789-5799. PubMed ID: 27494890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.
    Brooks SA; Brannon AR; Parker JS; Fisher JC; Sen O; Kattan MW; Hakimi AA; Hsieh JJ; Choueiri TK; Tamboli P; Maranchie JK; Hinds P; Miller CR; Nielsen ME; Rathmell WK
    Eur Urol; 2014 Jul; 66(1):77-84. PubMed ID: 24613583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Long Non-Coding RNAs for Predicting Prognosis Among Patients with Thymoma.
    Gong J; Jin S; Pan X; Wang G; Ye L; Tao H; Wen H; Liu Y; Xie Q
    Clin Lab; 2018 Jul; 64(7):1193-1198. PubMed ID: 30146820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.
    Mu Z; Dong D; Wei N; Sun M; Wang W; Shao Y; Gao J; Yin P; Zhao C
    Oncol Res; 2019 Jun; 27(6):653-661. PubMed ID: 30832752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Long Noncoding RNA APOC1P1 as an Oncogene in Clear Cell Renal Cell Carcinoma.
    Sun C; Zhou Z; Shi H; Li F; Zhang G
    Dis Markers; 2019; 2019():2814058. PubMed ID: 31871500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Analysis of N6-Methylandenosine-Related lncRNAs in Clear Cell Renal Cell Carcinoma: A Correlation With Prognosis, Tumor Progression, and Therapeutic Response.
    Meng C; Li J; Wang X; Ying Y; Li Z; Wang A; Li X
    Cancer Invest; 2024 Apr; 42(4):278-296. PubMed ID: 38644691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
    Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA NR2F2-AS1 Upregulates Rac1 to Increase Cancer Stemness in Clear Cell Renal Cell Carcinoma.
    Chen L; Zhang D; Ding T; Liu F; Xu X; Tian Y; Xiao J; Shen H
    Cancer Biother Radiopharm; 2020 May; 35(4):301-306. PubMed ID: 32109138
    [No Abstract]   [Full Text] [Related]  

  • 31. A Risk Signature with Autophagy-Related Long Noncoding RNAs for Predicting the Prognosis of Clear Cell Renal Cell Carcinoma: Based on the TCGA Database and Bioinformatics.
    Xuan Y; Chen W; Liu K; Gao Y; Zuo S; Wang B; Ma X; Zhang X
    Dis Markers; 2021; 2021():8849977. PubMed ID: 34040677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
    Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
    Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MFI2-AS1 regulates the aggressive phenotypes in glioma by modulating MMP14 via a positive feedback loop.
    Liu K; Liu J; Bo QF
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5884-5895. PubMed ID: 31298339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma.
    Cox A; Tolkach Y; Kristiansen G; Ritter M; Ellinger J
    Clin Transl Oncol; 2020 Sep; 22(9):1524-1531. PubMed ID: 31965534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients.
    Zhang M; Zhang J; Liang X; Zhang M
    BMC Med Genomics; 2024 May; 17(1):150. PubMed ID: 38822402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting LncRNA Roles in Renal Cell Carcinoma Metastasis and Characterizing Genomic Heterogeneity by Single-Cell RNA-seq.
    Li X; Meng X; Wei C; Zhou Y; Chen H; Huang H; Chen M
    Mol Cancer Res; 2018 Dec; 16(12):1879-1888. PubMed ID: 30082482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNAs enable precise diagnosis and prediction of early relapse after nephrectomy in patients with renal cell carcinoma.
    Bohosova J; Kozelkova K; Al Tukmachi D; Trachtova K; Naar O; Ruckova M; Kolarikova E; Stanik M; Poprach A; Slaby O
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7587-7600. PubMed ID: 36988708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4-miRNA Score Predicts the Individual Metastatic Risk of Renal Cell Carcinoma Patients.
    Heinzelmann J; Arndt M; Pleyers R; Fehlmann T; Hoelters S; Zeuschner P; Vogt A; Pryalukhin A; Schaeffeler E; Bohle RM; Gajda M; Janssen M; Stoeckle M; Junker K
    Ann Surg Oncol; 2019 Oct; 26(11):3765-3773. PubMed ID: 31270716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.